Cryptococcus neoformans is an opportunistic human pathogen, which infects the central nervous system causing the fatal disease, meningitis. In order to understand the genetic background of this human pathogen, the basic molecular manipulation techniques of deletion, overexpression, and so on have been developed. URA5, a gene encoding orotate phosphoribosyltransferase, has frequently been used to introduce foreign gene fragments by complementing ura5 mutant strains, which are not, however, stable; reversion to uracil prototroph is thus frequently observed on selective condition. The high possibility of reversion makes it inconvenient to use this mutation to identify appropriate transformants and thus, manipulation in molecular genetics. We report here the isolation of a stable ura5 mutant of C. neoformans, designated as TAD 1, by eliminating the URA5 gene by homologous recombination using the biolistic DNA delivery system. The availability of the stable ura5 mutant offers the advantage that no spontaneous reversion occurs so that a satisfactory rate of homologous recombination can be achieved. The strain will allow efficient genomic analysis in C. neoformans.
Introduction
Cryptococcus neoformans is an opportunistic human pathogen with worldwide distribution especially in the United States and in Europe. It infects the central nervous system causing meningitis, which is fatal if untreated. Although C. neoformans can occasionally cause disease in an apparently healthy host, it is primarily associated with therapeutic immunosuppression, neoplastic disease, and AIDS. Cryptococcocal infection, as well as many other fungal diseases, is thought to begin with inhalation of airborne fungal cells from an environmental source. The infectious strain may then remain in a dormant phase in the host. As soon as some kind of immune defect occurs, which for most is caused by AIDS, the fungus becomes able to multiply, disseminate and cause infection 1). In some cases, individuals with no apparent immune defect can also develop cryptococcosis.
Cryptococcus neoformans has some excellent properties for genetic manipulation. For example, this fungus is usually haploid which makes it amenable to genetic analysis by sexual cross. In addition, this property also gives us chances to modify its genome by molecular techniques, such as target gene disruption, controllable expression of genes of interest, green fluorescent protein study to track target gene products and so on. events presumably by the DNA repair system. In several studies, the frequency of homologous recombination that can be achieved with -1000 by of flanking sequence on each side of the selectable marker is in the range of 2% to 25%, with some exceptional cases at higher efficiency9-14).
The strains of C. neoformans with mutations in ura5 gene previously reported are not stable and reversion to uracil prototroph is frequently observed on selective medium6).
The high probability of reversion makes it inconvenient to use this mutation to identify appropriate transformants and thus, manipulation in molecular genetics. At present, no stable ura5 mutant is available as a tool for transformation in order to study the molecular genetics of C. neoformans. In this study, we describe the isolation of a stable ura5 mutant of C. neoformans by eliminating the URA5 gene by homologous recombination using the biolistic DNA delivery system 2). The availability of the stable ura5 mutant offers the advantage that the spontaneous reversion does not occur and a satisfactory rate of homologous recombination is achieved. The strain allows efficient genomic analysis in C. neoformans.
Materials and Methods

Strains and media
Cryptococcus neoformans strain B-450015), a serotype D, and B-4500 FOA16) were maintained on PDA (potato dextrose agar, Difco) slants at 30C for use. For C. neoformans experiments, minimal medium (MIN; 1.7 g yeast nitrogen base without amino acids and ammonium sulfate (Difco), 5 g ammonium sulfate, 20 g glucose per 1 liter) was used throughout the research unless otherwise stated. Twenty grams of agar was used for the solid medium. To isolate URA5 deletion strains, MIN medium were supplemented with 1 g/l of 5-FOA (5-fluoroorotic acid) and 50 mg/l of uracil (MINFOA). After screening of 5-FOA resistant strains, they were maintained on MIN supplemented with 50 mg/l uracil (MINURA). URA5 deletion strains grew only on MINURA agar or on YPG (10 g yeast extract, 10 g polypeptone, 10 g glucose per liter) agar supplemented with 50 mg/l uracil.
URA5 deletion construct Primers URA5-5.UP (5'-CTTGGTGGACTG-ATTGTGAT-3') and URA5-5.LP (5'-GAGTTT-GATTGGACGATTGGGAGGGATGGAGAGAC -3') were used to amplify the upstream flanking sequence of URA5 gene (URA5-5), and URA5-3.UP (5'-GTCTCTCATCCTCCAATCGTC-CAATCAAACTC-3') and URA5-3.LP (5'-CT-CC ACTTCCACTTC-3') were used to amplify the downstream flanking sequence of the URA5 gene (URA5-3). The underlined sequences correspond to the oligonucleotides for overlap connection by PCR. All PCR amplifications were performed using iCycler (Bio-Rad) with ExTaq polymerase (Takara). The initial two PCR fragments (URA5-5 and URA5-3) were amplified by 35 cycles of 15 sec at 96C, 15 sec at 55C and 2 min at 72C, following the initial denaturation for 4 min at 96C and followed by the final extension for 5 min at 72C. The PCR fragments were run on a 1% agarose gel and recovered from the gel with a QIAquick Gel Extraction Kit (Qiagen) aCording to the manufacturer's protocol. The two obtained fragments (URA5-5 and URA5-3) were then mixed to the equal mole, and used for the second PCR amplification. The second PCR was amplified by the same cycles except that the time period for extension was lengthened to 4 min. About a 2.3 kb fragment was yielded, and was purified with a QIAquick Gel Extraction Kit (Qiagen) following the agarose gel electrophoresis. The scheme of the URA5 deletion is outlined in Fig. 1 . In order to check the structure of the URA5 loci, URA5.UP (5'-GAGCGAAGTTGCT-CGAC3') and URA5.LP (5'-TTGCTCAG-GAGGTGG-3') were used for PCR amplification.
Transformation
For C. neoformans transformation, the biolistic DNA delivery strategy was employed as described by Davidson et al.8) . Cells were cultured until OD (A=660) reached 1, which is the late log phase of this fungus, in YPG medium at 30C with shaking at 110 rpm. Cells were collected by centrifugation and resuspended in sterilized water to the concentration of 5X108 cells per 1 ml. Two hundred microliters of this suspension was spread on MINFOA agar supplemented with 1 M sorbitol. These plates were then bombarded with DNA-coated gold beads in a vacuum chamber with a gas pressure of 1350 lb./in2 with a helium-driven biolistic system (BioRad) and then incubated at 30C for 3-5 days. Possible transformants which grew on MINFOA were then transferred to fresh MINFOA agar plates to obtain single isolates.
Growth assay
Fifty ml of MIN or MINURA medium was inoculated with 108 cells of each strain in a 100 ml flask. Cells were incubated at 30C with shaking at 110 rpm. At the time point of 2, 5, 9, 14 and 22 hours after inoculation, 3 ml of each culture was taken out for measurement. ODs were measured at A=660 nm. Experiments were repeated 3 times.
Genomic DNA isolation
Cryptococcus neoformans strains were cultured in 2 ml of YPG liquid medium, which was supplemented with uracil when needed. The cells of overnight culture were harvested into 2 ml microcentrifuge tubes by centrifugation, washed once with 1 ml of the sterilized water and frozen at -80C for 15 min. The cells were lyophilized for 3 hours. After complete lyophilization, they were then mixed with approximately 200 it of 0.45 mm glass beads and vortexed vigorously until fine powder was created. Then, 0.5 ml phenolchloroform and 0.5 ml TENTS buffer (10 mM TrisHCl, pH7.5; 1 mM EDTA, pH 8; 100 mM NaCI; 2% Triton X-100; 1% SDS) were added, mixed gently and centrifuged at 4C for 20 min at 13.2 rpm. The aqueous phase was transferred to a new microcentrifuge tube and DNA was precipitated by adding 3 M sodium acetate (pH 5.2) and ethanol. DNA was then pelleted by centrifugation, washed with 70% ethanol, dried and resuspended in 30ul of Tris-HCl (10 mM, pH 8) containing 10 ul/ml RNase. After incubation at 65C for 15 min to digest RNA, the samples were stored at -20C.
Results and Discussion
Deletion of URA5 gene of C. neoformans By biolistic delivery of the DNA fragment constructed by the overlap PCR technique (see Materials and Methods and Fig. 1 ) into C. neoformans B-4500 (wild type), we obtained about 200 possible transformants. They were tested for resistance against 5-FOA or auxotroph to uracil, and all the candidates were found resistant to 5-FOA and to require uracil, which is a typical phenotype of strains lacking genes encoding orotate phosphor ibosyltransferases or orotidine monophosphate pyrophosphorylases3,6). However, a control plate without bombarding DNA, also bore a significant number of colonies, and we then analyzed the structure of their genomes. Genomic DNA was extracted from the transformants obtained above, and was used for PCR with primers URA5-5.UP and URA5-3.LP.
If the strain has a wild type allele of URA5, a 4.2 kb fragment would be amplified while a mutant one would raise a 2.3 kb fragment.
We tested 200 strains obtained from biolistic transformation, and 37 of them were found likely to have only mutant alleles of URA5 ( Fig. 2A) , while others raised a 4.2 kb fragment (#61 in Fig. 2 ). We determined the nucleotide sequence of the fragment amplified with URA5-5.UP and URA5-3.LP in those transformants, and identified that the structure of the amplified fragment was actually lacking the entire URA5 gene, as we expected. We also performed PCR with primers URA5.UP and URA5.LP to amplify the entire URA5 gene, and those which showed amplification of shorter fragments with URA5-5.UP and URA5-3.LP lacked amplification of URA5 gene, whereas a wild type control or a transformant which had a wild type allele of URA5 (#61 in Fig. 2 ) allowed its amplification (Fig. 2B) . Three transformants lacking the complete URA5 gene isolated in this study were designated as TAD1, TAD2, and TAD3, respectively (see Fig. 3 ). In this study, only 37 out of 200 possible transformants turned out to have an expected homologous recombination, and the rest still kept the wild type URA5 gene, at least as speculated by the length of the PCR product amplified with URA5-5.UP and URA5-5.LP. Because of its ease of screening, the pyrimidine which is auxotrophic to uracil, did not grow, or showed minimum proliferation (Fig. 4A) . On the other hand, in MINURA, TAD1
showed a similar growth rate to the wild type control, suggesting that the supplement of uracil completely suppressed the growth deficiency of TAD1 (Fig. 4B) . We repeated the same experiment with different deletion strains (TAD2 and TAD3), and obtained the same results (data not shown).
Transformation efficiency of TAD1 We next questioned whether TAD1, the newly created URA5-strain, is actually useful for molecular genetics manipulation. We designed a PCR overlap construct to disrupt S. cerevisiae BCKI gene homolog in C. neoformans (unpublished data). Briefly, the deletion construct was made to insert URA5 gene as a selectable marker within the open reading frame of BCK1 homolog; detail of the construct will be published elsewhere. When B-4500 FOA was used as a recipient for transformation, 8 out of 28 possible transformants seemed to have the expected genome structure by a targeted homologous recombination (about 30%). On the other hand, withTAD1
, 6 out of 12 turned out to have disruption of the BCK1 homolog (50%). Thus, with TAD1, it is more efficient to obtain a transformant with an expected integration than with B-4500 FOA. Our interpretation of this difference includes: 1) TAD1 did not bear reversion to restore URA5 gene function while B-4500 FOA did, as described in our experiment above; 2) TAD1 did not have any homologous sequence to URA5 marker gene whereas B-4500 FOA did, so that B-4500 FOA allowed the BCKI disruption construct more frequently to integrate into its endogenous URA5 region. Although we did not analyze the state of integration in the transformants obtained in this experiment with BCKI disruption construct, we conclude that the newly created URA5 deletion strain would be a powerful tool in manipulation of genes in C. neoformans. 
